Literature DB >> 2982300

Isoproterenol or aminophylline attenuate pulmonary edema after acid lung injury.

I Mizus, W Summer, I Farrukh, J R Michael, G H Gurtner.   

Abstract

We tested the hypothesis that isoproterenol and aminophylline would reduce both the pulmonary hypertension and increased pulmonary vascular permeability caused by the intratracheal instillation of hydrochloric acid. The lungs of New Zealand white rabbits were studied using a blood-perfused isolated lung preparation. Changes in pulmonary artery pressure and lung weight were measured for 30 min after acid injury (2 ml/kg 0.1 N HCl). In a control group without acid injury, pulmonary artery pressure and lung weight did not change throughout 1 h of perfusion. In an acid control group, pulmonary artery pressure increased 11 +/- 3 mmHg (p less than 0.01), and lung weight increased 19.2 +/- 5.1 g during the 30 min after acid injury (p less than 0.001). Pretreatment with aminophylline (p less than 0.01) or isoproterenol (p less than 0.001) completely prevented the increase in pulmonary artery pressure after acid instillation. Pretreatment with aminophylline strikingly reduced the increase in lung weight caused by acid injury to 3.6 +/- 1.0 g over 30 min (p less than 0.01). Pretreatment with isoproterenol prevented any increase in lung weight (0.5 +/- 0.5 g over 30 min, p less than 0.01). Post-treatment with isoproterenol beginning 3 min after acid instillation also prevented the increase in pulmonary artery pressure (p less than 0.01) and markedly reduced the increase in lung weight to 5.8 +/- 2.4 g over 30 min (p less than 0.01). The beneficial effect of isoproterenol is mediated through activation of beta-adrenergic receptors because propranolol reverses its effect.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2982300     DOI: 10.1164/arrd.1985.131.2.256

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  6 in total

1.  Rab1 GTPase promotes expression of beta-adrenergic receptors in rat pulmonary microvascular endothelial cells.

Authors:  Yuncheng Li; Guansong Wang; Kexiong Lin; Hongjin Yin; Changxi Zhou; Ting Liu; Guangyu Wu; Guisheng Qian
Journal:  Int J Biochem Cell Biol       Date:  2010-04-24       Impact factor: 5.085

2.  Vascular barrier-enhancing effect of an endogenous beta-adrenergic agonist.

Authors:  Z Ding; M Jiang; S Li; Y Zhang
Journal:  Inflammation       Date:  1995-02       Impact factor: 4.092

3.  Effect of theophylline on beta-adrenergic receptor density and cAMP content in bovine aortic smooth muscle cells.

Authors:  K Graf; U Dümmler; M Grfe; A O'Connor; E Fleck; G Kunkel
Journal:  Inflamm Res       Date:  1995-08       Impact factor: 4.575

4.  Suppression by isoproterenol of endothelial cell morphology and barrier function changes induced by platelet-activating factor.

Authors:  Z Ding; S Li; M Jiang; Z Wu
Journal:  Inflammation       Date:  1994-10       Impact factor: 4.092

5.  cAMP and beta-adrenergic stimulation of rat alveolar epithelium. Effects on fluid absorption and paracellular permeability.

Authors:  G Saumon; G Basset; F Bouchonnet; C Crone
Journal:  Pflugers Arch       Date:  1987-11       Impact factor: 3.657

6.  Beta-2-adrenoceptor agonists as inhibitors of lung vascular permeability to radiolabelled transferrin in the adult respiratory distress syndrome in man.

Authors:  G S Basran; J G Hardy; S P Woo; R Ramasubramanian; A J Byrne
Journal:  Eur J Nucl Med       Date:  1986
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.